Dong-A ST Co., Ltd. (170900.KS)
KRW 45350.0
(0.78%)
KRW 45350.0
(0.78%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 116.31 Billion KRW | 16.14% |
| 2022 | 100.14 Billion KRW | -4.26% |
| 2021 | 104.59 Billion KRW | 0.03% |
| 2020 | 104.56 Billion KRW | -8.74% |
| 2019 | 114.57 Billion KRW | 11.13% |
| 2018 | 103.1 Billion KRW | 4.62% |
| 2017 | 98.55 Billion KRW | -6.92% |
| 2016 | 105.87 Billion KRW | 9.57% |
| 2015 | 96.62 Billion KRW | 11.49% |
| 2014 | 86.66 Billion KRW | -6.92% |
| 2013 | 93.1 Billion KRW | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 125.07 Billion KRW | 4.48% |
| 2024 Q1 | 119.71 Billion KRW | 2.92% |
| 2023 Q4 | 116.31 Billion KRW | -1.16% |
| 2023 Q1 | 110.93 Billion KRW | 10.78% |
| 2023 FY | 116.31 Billion KRW | 16.14% |
| 2023 Q3 | 117.67 Billion KRW | -2.95% |
| 2023 Q2 | 121.25 Billion KRW | 9.29% |
| 2022 FY | 100.14 Billion KRW | -4.26% |
| 2022 Q1 | 103.02 Billion KRW | -1.51% |
| 2022 Q2 | 97.72 Billion KRW | -5.14% |
| 2022 Q4 | 100.14 Billion KRW | 0.59% |
| 2022 Q3 | 99.55 Billion KRW | 1.88% |
| 2021 Q4 | 104.59 Billion KRW | -4.4% |
| 2021 Q2 | 104.16 Billion KRW | -5.1% |
| 2021 FY | 104.59 Billion KRW | 0.03% |
| 2021 Q1 | 109.76 Billion KRW | 4.98% |
| 2021 Q3 | 109.4 Billion KRW | 5.03% |
| 2020 Q1 | 100.44 Billion KRW | -12.34% |
| 2020 FY | 104.56 Billion KRW | -8.74% |
| 2020 Q4 | 104.56 Billion KRW | -1.83% |
| 2020 Q3 | 106.51 Billion KRW | -5.39% |
| 2020 Q2 | 112.57 Billion KRW | 12.08% |
| 2019 Q3 | 111.1 Billion KRW | -1.45% |
| 2019 Q4 | 114.57 Billion KRW | 3.13% |
| 2019 Q1 | 115.12 Billion KRW | 11.66% |
| 2019 FY | 114.57 Billion KRW | 11.13% |
| 2019 Q2 | 112.73 Billion KRW | -2.08% |
| 2018 FY | 103.1 Billion KRW | 4.62% |
| 2018 Q4 | 103.1 Billion KRW | 0.44% |
| 2018 Q3 | 102.64 Billion KRW | 1.45% |
| 2018 Q2 | 101.17 Billion KRW | -1.04% |
| 2018 Q1 | 102.23 Billion KRW | 3.74% |
| 2017 Q1 | 104.84 Billion KRW | -0.97% |
| 2017 Q2 | 101.53 Billion KRW | -3.15% |
| 2017 Q3 | 101.85 Billion KRW | 0.31% |
| 2017 Q4 | 98.55 Billion KRW | -3.24% |
| 2017 FY | 98.55 Billion KRW | -6.92% |
| 2016 Q2 | 102.66 Billion KRW | 4.44% |
| 2016 FY | 105.87 Billion KRW | 9.57% |
| 2016 Q4 | 105.87 Billion KRW | 5.3% |
| 2016 Q3 | 100.54 Billion KRW | -2.07% |
| 2016 Q1 | 98.3 Billion KRW | 1.74% |
| 2015 Q4 | 96.62 Billion KRW | 4.72% |
| 2015 FY | 96.62 Billion KRW | 11.49% |
| 2015 Q3 | 92.27 Billion KRW | -0.71% |
| 2015 Q2 | 92.92 Billion KRW | 10.26% |
| 2015 Q1 | 84.28 Billion KRW | -2.75% |
| 2014 FY | 86.66 Billion KRW | -6.92% |
| 2014 Q1 | 94.78 Billion KRW | 1.8% |
| 2014 Q2 | 93.6 Billion KRW | -1.25% |
| 2014 Q3 | 91.98 Billion KRW | -1.73% |
| 2014 Q4 | 86.66 Billion KRW | -5.79% |
| 2013 Q2 | 94.08 Billion KRW | 0.0% |
| 2013 Q3 | 90.57 Billion KRW | -3.73% |
| 2013 Q4 | 93.1 Billion KRW | 2.8% |
| 2013 FY | 93.1 Billion KRW | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Dongwha Pharm.Co.,Ltd | 70.69 Billion KRW | -64.524% |
| Yuhan Corporation | 284.75 Billion KRW | 59.154% |
| Yuhan Corporation | 284.75 Billion KRW | 59.154% |
| Yuyu Pharma, Inc. | 44.15 Billion KRW | -163.438% |
| Yuyu Pharma, Inc. | 44.15 Billion KRW | -163.438% |
| Yuyu Pharma, Inc. | 44.15 Billion KRW | -163.438% |
| Ildong Holdings Co., Ltd. | 91.16 Billion KRW | -27.584% |
| Samil Pharmaceutical Co.,Ltd | 32.51 Billion KRW | -257.762% |
| Dong-A Socio Holdings Co., Ltd. | 117.85 Billion KRW | 1.306% |
| JW Pharmaceutical Corporation | 106.09 Billion KRW | -9.635% |
| JW Pharmaceutical Corporation | 106.09 Billion KRW | -9.635% |
| JW Pharmaceutical Corporation | 106.09 Billion KRW | -9.635% |
| SAMSUNG PHARM. Co., LTD. | 16.25 Billion KRW | -615.394% |
| Chong Kun Dang Holdings Corp. | 194.76 Billion KRW | 40.28% |
| Dong Sung Bio Pharm.Co.,Ltd. | 19.47 Billion KRW | -497.182% |
| HANDOK Inc. | 94.46 Billion KRW | -23.129% |
| Jeil Pharma Holdings Inc | 125.28 Billion KRW | 7.157% |
| Kukje Pharma Co., Ltd. | 21.24 Billion KRW | -447.536% |
| Bukwang Pharmaceutical Co., Ltd. | 56.83 Billion KRW | -104.663% |
| Aprogen pharmaceuticals,Inc. | 48.12 Billion KRW | -141.675% |
| Ilsung Pharmaceuticals Co., Ltd. | 31.24 Billion KRW | -272.313% |
| Daewon Pharmaceutical Co., Ltd. | 105.07 Billion KRW | -10.693% |
| Yungjin Pharm. Co., Ltd. | 61.98 Billion KRW | -87.643% |
| Boryung Corporation | 189.8 Billion KRW | 38.72% |
| Hyundai Pharmaceutical Co., Ltd. | 26.99 Billion KRW | -330.823% |
| Samjin Pharmaceuticals Co., Ltd. | 79.6 Billion KRW | -46.117% |
| Ilyang Pharmaceutical Co.,Ltd | 61.72 Billion KRW | -88.439% |
| Ilyang Pharmaceutical Co.,Ltd | 61.72 Billion KRW | -88.439% |
| Suheung Co., Ltd. | 259.84 Billion KRW | 55.237% |
| Kwang Dong Pharmaceutical Co., Ltd. | 188.64 Billion KRW | 38.342% |
| Hanall Biopharma Co.,Ltd | 32.38 Billion KRW | -259.168% |
| Whan In Pharm Co.,Ltd. | 54.05 Billion KRW | -115.165% |
| MYUNGMOON Pharm co.,Ltd | 30.28 Billion KRW | -284.124% |
| Shin Poong Pharm.Co.,Ltd. | 53.92 Billion KRW | -115.702% |
| Shin Poong Pharm.Co.,Ltd. | 53.92 Billion KRW | -115.702% |
| Korea United Pharm Inc. | 49.14 Billion KRW | -136.689% |
| CKD Bio Corp. | 69.08 Billion KRW | -68.37% |
| Daewoong pharmaceutical Co.,Ltd | 241.54 Billion KRW | 51.846% |
| JW Holdings Corporation | 147.58 Billion KRW | 21.191% |
| REYON Pharmaceutical Co., Ltd. | 35.17 Billion KRW | -230.658% |
| Hanmi Pharm. Co., Ltd. | 288.81 Billion KRW | 59.727% |
| Chong Kun Dang Pharmaceutical Corp. | 261.43 Billion KRW | 55.509% |
| JW Lifescience Corporation | 23.39 Billion KRW | -397.096% |
| Ildong Pharmaceutical Co., Ltd. | 84.62 Billion KRW | -37.448% |
| Jeil Pharmaceutical Co.,Ltd | 109.76 Billion KRW | -5.963% |
| Hana Pharm Co., Ltd. | 48.34 Billion KRW | -140.579% |